1-9 of 9
MA Goldberg
Close
Sort by
Journal Articles

Use of recombinant human erythropoietin in allogeneic bone marrow transplant donor/recipient pairs

AJ Mitus, JH Antin, CJ Rutherford, CJ McGarigle, MA Goldberg
Journal: Blood
Blood (1994) 83 (7): 1952–1957.
https://doi.org/10.1182/blood.V83.7.1952.1952
Published: 1994
Journal Articles

Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects [see comments]

C Brugnara, LA Chambers, E Malynn, MA Goldberg, MS Kruskall
Journal: Blood
Blood (1993) 81 (4): 956–964.
https://doi.org/10.1182/blood.V81.4.956.956
Published: 1993
Journal Articles

Effect of inflammatory cytokines on hypoxia-induced erythropoietin production

WC Faquin, TJ Schneider, MA Goldberg
Journal: Blood
Blood (1992) 79 (8): 1987–1994.
https://doi.org/10.1182/blood.V79.8.1987.1987
Published: 1992
Journal Articles

Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscriptional events

MA Goldberg, CC Gaut, HF Bunn
Journal: Blood
Blood (1991) 77 (2): 271–277.
https://doi.org/10.1182/blood.V77.2.271.271
Published: 1991
Journal Articles

Regulatory elements of the erythropoietin gene

S Imagawa, MA Goldberg, J Doweiko, HF Bunn
Journal: Blood
Blood (1991) 77 (2): 278–285.
https://doi.org/10.1182/blood.V77.2.278.278
Published: 1991
Journal Articles

Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy

L Schapira, JH Antin, BJ Ransil, KH Antman, JP Eder, CJ McGarigle, MA Goldberg
Journal: Blood
Blood (1990) 76 (11): 2354–2359.
https://doi.org/10.1182/blood.V76.11.2354.2354
Published: 1990
Journal Articles

Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients

RM Stone, M Maguire, MA Goldberg, JH Antin, DS Rosenthal, RJ Mayer
Journal: Blood
Blood (1988) 71 (3): 690–696.
https://doi.org/10.1182/blood.V71.3.690.690
Published: 1988
Journal Articles

Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia?

MA Goldberg, D Ginsburg, RJ Mayer, RM Stone, M Maguire, DS Rosenthal, JH Antin
Journal: Blood
Blood (1987) 69 (1): 187–191.
https://doi.org/10.1182/blood.V69.1.187.187
Published: 1987
Journal Articles

Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor

MA Goldberg, JH Antin, EC Guinan, JM Rappeport
Journal: Blood
Blood (1986) 68 (5): 1114–1118.
https://doi.org/10.1182/blood.V68.5.1114.1114
Published: 1986